Literature DB >> 11111961

Sub-clinical acute rejection detected using protocol biopsies in patients with delayed graft function.

S Jain1, V Curwood, S A White, P N Furness, M L Nicholson.   

Abstract

Acute rejection in renal transplants is difficult to diagnose when patients have delayed graft function (DGF) in the early post-transplant period. In this study protocol, renal transplant biopsies were performed in an attempt to detect sub-clinical acute rejection episodes. Eighty-three patients were eligible for the study, of whom 33 had DGE All had protocol renal transplant biopsies performed under ultrasound control at 7 days post-transplant, and those with DGF had further biopsies weekly until the graft functioned. All histologically confirmed acute rejection episodes were treated. Sub-clinical acute rejection was detected in 6/33 (18%) patients with DGF compared to 2/50 (4%) in the other patients (P < 0.05). Borderline rejection was present in 4/33 (12%) and 4/50 (8%) patients, respectively. Because of the high detection rate of sub-clinical acute rejection and the low morbidity of renal transplant biopsies, their use is recommended in patients with DGF.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11111961     DOI: 10.1007/s001470050274

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  4 in total

1.  Utility and safety of early allograft biopsy in adult deceased donor kidney transplant recipients.

Authors:  Evaldo Favi; Ajith James; Carmelo Puliatti; Phil Whatling; Mariano Ferraresso; Chiara Rui; Roberto Cacciola
Journal:  Clin Exp Nephrol       Date:  2019-11-25       Impact factor: 2.801

2.  Protocol biopsies should not (yet) be the standard of care in pediatric renal transplant recipients.

Authors:  Ron Shapiro; Thomas E Starzl
Journal:  Pediatr Transplant       Date:  2006-11

3.  Transplant and Recipient Factors in Prediction of Kidney Transplant Outcomes: A UK-Wide Paired Analysis.

Authors:  Richard Dumbill; Roderick Jaques; Matthew Robb; Rachel Johnson; Rutger J Ploeg; Maria E Kaisar; Edward J Sharples
Journal:  J Clin Med       Date:  2022-04-15       Impact factor: 4.964

4.  Low-dose Rituximab and Thymoglobulin Induction With Steroid-free Maintenance Immunosuppression and Protocol Biopsies Improves Long-term Patient and Graft Survival After Kidney Transplantation: Survival and Safety Outcomes in More Than 1100 Patients From a Single Center.

Authors:  Vivek Pathak; Devdas Madhavan; Kuppurajan Narayanasamy; Sampath Kumar; Vasanthan Ramalingam; Balasundaram Sengodagounder; Gabor Bodonyi-Kovacs
Journal:  Transplant Direct       Date:  2019-07-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.